Status: Recruiting
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
The purpose of this study is to evaluate the safety and effectiveness of the experimental drug PTX-022 in the treatment of angiokeratomas
Participants needed: 15
Trial details
Phase: Phase 2Age: 6+Biological sex: AllType: InterventionalSponsor: Palvella Therapeutics, Inc.Updated: Apr 27, 2026Locations: 4
Eligibility criteria
Participants must be 6 years or older [+3]
Any significant concurrent condition that could adversely affect participation [+2]